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Abstract
Background: The formation of intraarticular adhesion is a common complication after total knee arthroplasty or
anterior cruciate ligament reconstruction. Previously, little research was reported regarding whether the local
application of rapamycin (RAPA) could reduce intraarticular adhesion following knee surgery. In our present study,
we determined the therapeutic effect of RAPA by local application on the reduction of intraarticular adhesion
following knee surgery in rabbits.
Methods: In this study, we built the model of knee surgery according to a previous study. The decorticated areas
of the cortical bone were exposed and covered with cotton pads soaked with different concentrations of RAPA
or physiological saline for 10 min. All of the rabbits were euthanized 4 weeks after the surgery. Macroscopic evaluation
of the hydroxyproline content, the histological morphological analysis and collagen density and fibroblast density were
used to evaluate the effect of RAPA on reducing intraarticular adhesion.
Results: The results shown that RAPA could significantly inhibit the proliferation of fibroblasts and reduce collagen
synthesis; in the rabbit model of knee surgery, there were weak scar tissues around the decorticated areas in the 0.2 mg/
ml RAPA group; moderate scar tissues were found in the 0.1 mg/ml RAPA group. However, severe fibrous adhesions were
found in the 0.05 mg/ml RAPA group and the control group. The hydroxyproline content and the fibroblast density in
the 0.2 mg/ml and 0.1 mg/ml RAPA groups were significantly less than those of the control group.
Conclusions: We concluded that the local application of RAPA could reduce intraarticular adhesion after knee surgery in
the rabbit model; this effect was mediated by inhibition of fibroblast proliferation and collagen synthesis, which
may provide a new method for reducing intraarticular adhesion after clinical knee surgery.
Keywords: Rapamycin, Intraarticular adhesion, Fibroblast, Collagen synthesis
Background
Intraarticular adhesion after knee trauma or ligament sur-
gery is a disabling complication in orthopaedics [1, 2]. Re-
strictive adhesions after knee surgery cause many issues for
patients who often suffer joint stiffness and pain. Because
intraarticular adhesion will further affect the biomechanics
of the knee, it will accelerate cartilage degeneration and
eventually lead to irreversible damage [3–5].
Currently, the underlying mechanisms of intraarticular
adhesion remain unclear. However, some researchers think
that many cytokines and growth factors can contribute to
fibrous tissue hyperplasia, which may be partially respon-
sible for the formation of intraarticular adhesion [6–8].
It is generally recognized that trauma itself and surgical
trauma will activate inflammatory responses. Subse-
quently, cytokines and growth factors are produced,
and they will stimulate fibroblasts to proliferate
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excessively. Fibroblasts produce collagen and release
extracellular matrix, which ultimately results in the for-
mation of intraarticular adhesion [9–11].
Several approaches, such as minimally invasive sur-
gery and careful haemostasis, have been used to prevent
intraarticular adhesion [12, 13]. Moreover, researchers
have reported a variety of medicines and artificial syn-
thetic materials that have been used to prevent intraar-
ticular adhesions [14–16]; however, limited or variable
success was achieved. Therefore, new solutions to solve
this problem are still greatly needed.
Rapamycin (RAPA) is a new cyclic macrolide antibiotic
that is widely used to inhibit organ allograft rejection
(such as corneal allograft and renal transplantation) be-
cause of its lack of renal toxicity in clinical trials [17, 18].
The local application of RAPA has been proven to be ef-
fective in inhibiting neointimal hyperplasia and vein graft
restenosis in experimental vein grafts [19, 20]. Many stud-
ies have reported that RAPA has proven to be effective in
preventing various reasons caused pulmonary fibrosis,
liver fibrosis and peritoneal fibrosis [21–23]. Recently,
RAPA has shown the effect when used systemically to
prevent scleroderma and corneal scarring after photo-
refractive keratectomy [24–26]. However, whether it
has the effect of preventing intraarticular adhesion after
knee surgery is unknown.
In the present study, we intended to illustrate the ef-
fect of RAPA on the reduction of intraarticular adhesion
after knee surgery in the rabbit model. If the local appli-
cation of RAPA proves to be an effective solution, it will




Forty-eight mature male New Zeal rabbits weighing 3.5 to
4.0 kg were purchased from Shanghai Laboratory Animal
Center (Shanghai, China). All of the animals were housed
in a controlled environmental condition to acclimate to
the environment for 1 week before surgery. The animals
were given normal chow and water. The rabbits were ran-
domly divided into four groups as follows (12 rabbits in
each group): A group: 0.2 mg/ml RAPA group; B group:
0.1 mg/ml RAPA group; C group: 0.05 mg/ml RAPA
group; and D group: control (saline) group.
Reagents
RAPA was obtained from Santa Cruz Biotechnology
(Santa Cruz, CA).
Animal model
The animal models of intraarticular adhesions were per-
formed according to the procedures of previous research
[1, 27]. Briefly, after animals were anaesthetized by
intravenous administration of 10 % pentobarbital sodium
(4 ml/kg), the hairs around the left knee joint were shaved
and the exposed skin was sterilized with iodophor three
times. A medial parapatellar approach was used to open
the medial and lateral sides of the femoral condyle. Then,
approximately 1 × 1 cm2 of the bone cortex was re-
moved from both sides of the femoral condyle, and the
underneath cancellous bone was exposed. The articular
cartilage was left intact.
Local application of drugs
Cotton pads soaked with various concentrations of 0.2,
0.1, and 0.05 mg/ml RAPA or normal saline were applied
for 10 min to the decorticated areas of the femoral con-
dyle (15 × 15 mm) after satisfactory haemostasis. The sur-
rounding tissues were protected using wet gauze to avoid
exposure with the agent. After the cotton pads were re-
moved, the decorticated areas of the femoral condyle were
washed immediately with enough saline to remove the
remaining RAPA. The articular capsule and skin were
closed with silk sutures, and the surgical knee joints were
fixed extraarticularly in the fully flexed position with a
Kirschner wire for 4 weeks. Cefazolin sodium (50 mg/kg)
was administered intramuscularly to prevent infection
postoperatively for 3 days. The animals were bred indi-
vidually with free access to standard chow and water
after surgeries.
Macroscopic evaluation
The macroscopic evaluation was performed postopera-
tively after 4 weeks. Four rabbits were randomly selected
from each group, and anaesthetized by intravenous ad-
ministration of 10 % pentobarbital sodium (4 ml/kg). The
intraarticular adhesions were evaluated by three profes-
sional pathologists who were blinded to the treatment
groups according to the following visual scoring system
[28]: grade 0: no adhesions; grade 1: weak, mild, filmy ad-
hesions that can be easily dissected by minimal manual
traction; grade 2: moderate adhesions that can be dis-
sected by manual traction; and grade 3: dense and firmly
fibrous adhesions that must be surgically removed.
Biochemical analysis of the hydroxyproline content
Four rabbits were euthanized with an overdose of urethane
and served for further biochemical analysis. The hydroxy-
proline content in the adhesion tissue was determined ac-
cording to the method of Woessner [29]. The knee was
opened, and approximately 20 mg wet weight of the adhe-
sion tissue was obtained from the centre of the decorticated
areas. The samples were lyophilized, ground separately and
hydrolysed. Then, the samples were neutralized with 2.5 N
NaOH on the indication of methyl red. The chloramine T
was added to the hydrolysed samples and hydroxyproline
standards of four known concentrations. After incubation
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at room temperature, the hydroxyproline developer was
added to the samples and the standards. The absorbance of
the solution was determined at 558 nm with the spectro-
photometer, and the levels of hydroxyproline per milligram
of scar tissue were calculated according to the standard
curve that constructed by the serial concentration of com-
mercial hydroxyproline.
Histological analysis
The histological analysis was performed in four groups
postoperatively after 4 weeks. Four rabbits were selected
from each group and euthanized with an overdose of ureth-
ane. The knee joints were excised including all of the con-
nective tissues and the fibrotic adhesive scar. The samples
were fixed in 10 % buffered formalin for 1 week and decal-
cified for 2 weeks. The tissues were embedded in paraffin,
and transverse sections perpendicular to the femoral axis
were stained with haematoxylin–eosin (HE). The intraarti-
cular scar adhesions were evaluated under the light micro-
scope with a magnification of ×200. Histological images
(magnification ×200) of the sections stained with HE from
each rabbit were obtained. Three counting areas in the
scar tissue close to the bottom of the decorticated areas
were selected, and each was approximately 100 × 100 μm.
The density of the fibroblasts was calculated, and the
density of the fibroblasts for each section was defined as
the mean number from three fields.
Densitometric analysis of collagen tissue
The optical density of collagen was observed using a
light microscope at a magnification of ×200. A densito-
metric analysis of the collagen tissue was also performed.
The sections stained with Masson’s trichrome were
photographed using a light microscope (Olympus BX50,
Japan) connected to a CCD camera (Olympus DP70,
Japan). The optical density value of the positively stained
collagen was determined using Image Pro Plus 6.0 image
analysis software.
Statistical analysis
The statistical analysis was performed using SPSS soft-
ware (version 13.0). The data were expressed as mean ±
standard deviation values. The differences were consid-
ered statistically significant when P < 0.05.
Results
Macroscopic evaluation of intraarticular adhesion
The surgery was well tolerated by all animals, and there
was no case of wound infection or disturbance of wound
healing in any of the rabbits. The macroscopic observation
showed that soft or weak fibrous adhesion was observed
around the decorticated areas of the femoral condyle in
0.2 mg/ml RAPA group. In the 0.1 mg/ml RAPA group,
the decorticated areas were covered with moderate scar
adhesion, which could be dissected by manual traction.
However, dense and tenacious fibrous adhesions were ob-
served around the decorticated areas of the femoral con-
dyle in the 0.05 mg/ml RAPA and control group, which
were difficult to dissect because the scar adhesions were
accompanied with bleeding. The degree of intraarticular
adhesions was evaluated according to the visual scoring
system, and the results are shown in Table 1.
Biochemical analysis of hydroxyproline content
The statistical analysis of the hydroxyproline content in
the intraarticular scar tissue for each group is shown in
Fig. 1. The hydroxyproline content in the 0.2 mg/ml
RAPA group was 23.94 ± 1.84 μg/mg, which was signifi-
cantly less than those in the 0.1 mg/ml RAPA group
(33.75 ± 4.31 μg/mg, P = 0.022), the 0.05 mg/ml RAPA
group (44.50 ± 4.35 μg/mg, P = 0.002) and the control
group (48.37 ± 4.43 μg/mg, P = 0.001). The content in
the 0.1 mg/ml RAPA group was also less than those in
the 0.05 mg/ml RAPA group (P = 0.039) and the control
group (P = 0.015). However, the content in the 0.05 mg/
ml RAPA group showed no significant difference com-
pared with those of the control group (P = 0.341).
Histological analysis of RAPA on intraarticular adhesion
In the control group, dense scar adhesions were found
around the decorticated areas of the femoral condyle,
which tethered the surrounding soft tissues to the femur.
In the 0.1 mg/ml RAPA group, mild scar tissues were
observed around the decorticated areas compared with
those of 0.05 mg/ml RAPA group and the control group.
However, loose fibrous adhesion tissue was observed in
the 2.0 mg/ml RAPA group. The representative images
of the HE staining of the scar tissues in each group are
shown in Fig. 2.
Collagen density analysis of RAPA on intraarticular scar
adhesion
Masson’s trichrome staining revealed that the collagen
density of the intraarticular adhesion tissue in the RAPA
groups coincided with HE staining. The collagen density
of intraarticular tissue in the 0.05 mg/ml RAPA group
Table 1 Knee intraarticular adhesion grade was based on the
visual scoring system
Group Grade
0 1 2 3
Saline 0 0 0 4
0.05 mg/ml 0 0 1 3
0.1 mg/ml 2 2 0 0
0.2 mg/ml 3 1 0 0
Four rabbits were selected from each group. The values within the table
represent the number of rabbits
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(Fig. 3c) and the control group (Fig. 3d) was strong.
However, the collagen density was weak in the 0.2 mg/
ml RAPA (Fig. 3a) and 0.1 mg/ml RAPA group (Fig. 3b),
which revealed a significant decrease compared with those
in 0.05 mg/ml RAPA group and control group. Moreover,
the collagen density in the 0.2 mg/ml RAPA group also re-
vealed a decrease compared with that in the other RAPA
groups. The representative images of Masson’s trichrome
staining in each group are shown in Fig. 3. The statistical
analysis of the optical density of the collagen tissues in
each group is shown in Fig. 4.
Effect of RAPA on the density of fibroblasts
The fibroblast density in the scar tissue in the 0.2 mg/ml
RAPA group was 21.66 ± 3.05, which was significantly less
than those of the 0.1 mg/ml RAPA group (29.33 ± 2.51,
P = 0.028), the 0.05 mg/ml RAPA group (37.66 ± 3.05,
P = 0.003) and the control group (41.0 ± 3.46, P = 0.002).
The density of the fibroblasts in the 0.1 mg/ml RAPA
group was also less than those of the 0.05 mg/ml RAPA
group (P = 0.022) and the control group (P = 0.009). How-
ever, the fibroblast density in the 0.05 mg/ml RAPA group
showed no significant difference compared with those of
the control group (P = 0.279). The statistical analysis re-
sults of the fibroblast density in the intraarticular scar tis-
sue of each treatment group are shown in Fig. 5.
Discussion
The study showed that the local application of 0.2 mg/ml
RAPA could reduce intraarticular fibrous adhesion through
inhibition of fibroblast proliferation and collagen synthesis
in rabbit models. Currently, the mechanisms of intraarticu-
lar adhesion formation still remain unclear, but fibroblasts
were generally recognized as a major reason for the forma-
tion of intraarticular adhesion [30, 31]. Following knee
surgery, many growth factors and inflammatory cytokines
will migrate to the surgical sites, where they will
Fig. 1 Hydroxyproline content in intraarticular scar tissue in the
RAPA-treated groups and the control group. The hydroxyproline
content is expressed as micrograms per milligram (μg/mg). *P < 0.05,
compared with control group; #P < 0.05, and the 0.2 mg/ml RAPA
group compared with the other RAPA groups
Fig. 2 The histological view of the intraarticular adhesion issues in the decorticated areas treated with RAPA (0.2 mg/ml (a), 0.1 mg/ml (b) and
0.05 mg/ml (c)) and saline (d). Note that loose scar tissues were found in the decorticated areas treated with the 0.1 mg/ml group and 0.2 mg/ml
RAPA group. Dense scar tissue was found in the decorticated areas treated with saline. The sections were stained with HE (×200)
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stimulate fibroblasts; then, fibroblasts produce the
collagen fibres to repair the damaged tissues. With
further changes of pathology, fibroblasts are trans-
formed into fibrocytes, and the fibrous connective tis-
sues finally transformed into scar tissues [27, 32].
Moderate scar tissues were helpful in repairing the
damaged tissues; however, if too many scar tissues
were formed, they adhere to the surrounding tissues
of the joint, which results in limited motion of knee,
pain, stiffness and a severe decrease in a patient’s
quality of life.
Although some techniques, such as manipulation under
anaesthesia, arthroscopic lysis and open debridement, are
used to relieve intraarticular scar adhesion, the surgical re-
lease of scar tissues can stimulate fibrous tissue
reproduction, finally resulting in unsatisfactory results of
the surgeries [33, 34]. Therefore, the ideal solution seems
to be the application of an anti-adhesion medicine to
Fig. 3 The collagen density of intraarticular adhesion tissue in the RAPA groups (0.2mg/ml (a), 0.1mg/ml (b), 0.05mg/ml (c) and the control
group (d). The collagen tissues show blue in the section with Masson’s trichrome staining under the light microscope (×200). RAPA could reduce
collagen synthesis and fibrosis. The density of collagen tissue in the 0.2 mg/ml RAPA group and the 0.1 mg/ml RAPA group revealed a significant
decrease compared with those in the 0.05 mg/ml RAPA group and control group
Fig. 4 The collagen optical density in each group. *P < 0.05,
compared with the control group; #P < 0.05, and the 0.2 mg/ml
RAPA group compared with the other RAPA groups
Fig. 5 Fibroblast counts of scar adhesion tissues from each group.
*P < 0.05, compared with the control group; #P < 0.05, the 0.2 mg/ml
RAPA group compared with the other RAPA-treated groups
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prevent formation of scar tissue. There are reports de-
scribing continuous decorin administration and intraarti-
cular chitosan injection to prevent fibrous adhesion
achieved some success [32, 35].
For a long time, RAPA has been known to have thera-
peutic effects on various types of fibrosis such as renal
fibrosis, cystic fibrosis, hepatic fibrosis and peritoneal fi-
brosis [36–39]. Recently, it was found that RAPA could
impair the process of collagen production of fibroblasts
from hypertrophic and keloid scars [40, 41]; RAPA could
inhibit the production of myofibroblasts and reduce cor-
neal scarring after photorefractive keratectomy [26]. Stud-
ies demonstrated that the mammalian target of rapamycin
(mTOR) plays a key role in the regulation of excessive de-
position of extracellular matrix components such as colla-
gen, fibronectin and TGF-β [40, 42]. Phosphorylation of
the ribosomal protein S6, a marker of mTOR (a mamma-
lian target of rapamycin) pathway activation, is strongly
increased in hypertrophic scars and keloids; RAPA is the
inhibitor of mTOR, which could downregulate the expres-
sion of collagen and fibronectin [41]. Similarly, it was re-
ported that RAPA could modulate and downregulate the
expression of collagen and MMP-1 in fibroblasts [43].
Therefore, RAPA may be a potential therapeutic agent for
the treatment of intraarticular scar adhesion.
In this study, we applied different concentrations of
RAPA to reduce intraarticular adhesion. Collagen is an
important component of scar tissue that is primarily
synthesized and secreted by fibroblasts. Moreover, hy-
droxyproline accounts for 12.5 % of the amino acid con-
tent of collagen fibres; thus, the hydroxyproline content
may reflect the formation of collagen in scar tissue [29].
Our data indicated that 0.2 mg/ml and 0.1 mg/ml RAPA
could reduce intraarticular fibrous adhesion through inhib-
ition of fibroblast collagen synthesis in a dose-dependent
manner. In the animals treated with 0.2 mg/ml of RAPA,
intraarticular adhesion became soft and weak around the
decorticated areas of the femoral condyle macroscopically,
which was consistent with the histological observation. The
adhesion score, the hydroxyproline content and the fibro-
blast density were also significantly decreased compared
with those of the control group. In the 0.1 mg/ml RAPA
group, moderate adhesion tissues were found around the
decorticated areas by macroscopical and histological obser-
vations. The hydroxyproline content and the fibroblast
density were also less than those of the 0.05 mg/ml RAPA
and control group. However, the 0.05 mg/ml RAPA group
failed to reduce intraarticular fibrous adhesion through
inhibiting fibroblast proliferation. Dense adhesions were
obviously observed around the decorticated areas in the
0.05 mg/ml RAPA group. The adhesion score, the hy-
droxyproline content and the density of fibroblasts in
0.05 mg/ml RAPA group showed no significant differ-
ences compared with the control group. Therefore, these
results showed that RAPA is an effective pharmaceutical
agent for the prevention of intraarticular adhesion after
knee surgery.
However, in the present study, we only investigated
the effect of RAPA on reducing intraarticular adhesion
by morphology and histology, which involved very basic
scientific techniques and more in-depth studies should
be conducted as a follow-up.
Conclusions
The local application of RAPA could reduce intraarticular
adhesion after knee surgery in rabbit models by inhibiting
proliferation of fibroblasts and decreasing collagen synthe-
sis, which may provide a new idea for reducing intraarti-
cular adhesion after knee surgery in the clinical setting.
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